CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE

  • CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE

    The Binaytara Foundation requires the following disclosures for all CME activities

  • Disclosure of Financial Relationship

    It is the policy of the Binaytara Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its direct or jointly provided educational programs. Conflicts of interest develop when an individual has an opportunity to affect Continuing Education (CE) content, introducing or promoting products or services of an ineligible company (formerly commercial interest) with which he/she has a relevant financial relationship.

    ACCME definition of an ineligible company: Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:

    • Advertising, marketing, or communication firms whose clients are ineligible companies
    • Bio-medical startups that have begun a governmental regulatory approval process
      Compounding pharmacies that manufacture proprietary compounds
    • Device manufacturers or distributors                              
    • Diagnostic labs that sell proprietary products
    • Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
    • Manufacturers of health-related wearable products
    • Pharmaceutical companies or distributors
    • Pharmacy benefit managers
    • Reagent manufacturers or sellers

    The existence of any relevant financial interest or other relationship a faculty member currently has, or has had within the last 24 -months with the commercial supporter(s) of this educational activity or with an ineligible company as defined above, shall be disclosed.

    The intent of this policy is to openly identify any such relationships so that a) Binaytara Foundation can identify any conflict of interest that may exist, and b) so that learners may form their own opinions as to whether the speaker's presentation reflects possible bias in either exposition or conclusion. The existence of any such financial interests or relationships shall be disclosed to participants prior to educational activities in brief statements, in conference materials such as brochures, syllabi, exhibits, and poster sessions, and in post-meeting publications. 

    The purpose of this form is to identify and mitigate all potential conflicts of interest that arise from financial relationships with any commercial or proprietary entity relevant to the content you are planning, developing, or presenting for this activity. 

  • Disclosure of Unlabeled/Investigational Uses of Products

    Faculty shall disclose when an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose, is discussed during an educational activity.  Faculty shall disclose that the product is not labeled for the use under discussion or that the product is still investigational. 
    The intent of this policy is not to prohibit or limit the exchange of views in scientific and educational discussions, including discussions of unapproved uses, but to ensure that faculty disclose to participants that such discussion will take place.
    It is standard procedure of the Binaytara Foundation to acknowledge the type of disclosure - i.e., nothing to disclose, affiliation(s) and/or financial interest(s) disclosed, that unapproved or investigational uses of products will be discussed, and failure of faculty to make disclosure by the established deadline.  Failure to disclose or false disclosure may result in disqualification from participation, and may require the Binaytara Foundation to identify a replacement for faculty.

  • Professional Title*
  • Role in Activity*
  • Disclosure of Financial Relationships*
  • Disclosure of Unlabeled/Investigational Uses of Products*
  • The content and/or presentation of the information with which I am involved will promote quality or improvements in healthcare and will not promote a specific proprietary business interest of a commercial interest. Content for this activity, including any presentation of therapeutic options, will be well-balanced, evidence-based, and unbiased.*
  • I have not and will not accept any honoraria, additional payments or reimbursements beyond that which has been agreed upon directly with the Binaytara Foundation or its designees.*
  • I understand that the Binaytara Foundation or its designees may need to review my presentation and/or content prior to the activity, and I will provide educational content and resources in advance as requested.*
  • I verify that prior to the presentation, I have requested and/or obtained permission from copyright holder(s) to reproduce/copy, from their work, the portions of my presentation that are protected by copyright laws. I acknowledge that the Binaytara Foundation will not be held legally responsible for any misrepresentation on my part regarding copyright infringement.*
  • If presenting specific patient cases or case histories, I warrant that I have Health Information and Portability and Accountability Act (HIPAA) compliant authorization for any Protected Health Information (PHI) in the presentation materials or have de-identified all materials in order to protect patients’ privacy.*
  • If I am providing recommendations involving clinical medicine, they will be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME/CE in support of justification of a patient care recommendation will conform to the generally accepted standards of experimental design, data collection and analysis.*
  • If I am discussing specific healthcare products or services, I will use generic names to the extent possible. If I need to use trade names, I will use trade names from several companies when available, and not just trade names from any single company.*
  • If I have been trained or utilized by a commercial entity or its agent as a speaker (e.g., Speaker's Bureau) for any commercial interest, the promotional aspects of that presentation will not be included in any way with this activity.*
  • If I am presenting research funded by a commercial company, the information presented will be based on generally accepted scientific principles and methods, and will not promote the commercial interest of the funding company.*
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof

  • I have read the Binaytara Foundation policy on full disclosure.  If I have indicated a relevant financial relationship, or if I will discuss unapproved or investigational uses of products or devices, I understand that I am responsible for disclosing this information to participants at the beginning of my presentation/material.  I understand that failure to disclose or false disclosure may require the Binaytara Foundation to identify a replacement for my participation or revoke CE eligibility.

  • Date
     - -
  • Should be Empty: